Fennec Pharmaceuticals develops and sells PEDMARK, a sodium thiosulfate injection, from Research Triangle Park, North Carolina. It last closed at $13.09 on Nov 20, down 2.68% on the day. For the quarter ended Sep 2026, FENC reported EPS of $0.12 on revenue of $19.6M, with revenue up 57.3% from a year ago. Over its last 5 reports the stock moved an average of 2.2% the session after earnings. Over the last 12 months FENC insiders bought $0 of stock on the open market and sold $9.9M, according to SEC Form 4 filings.
AI Auto Pilots
Is FENC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold FENC.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on FENCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
FENC · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought
The stock is 14% above its 20 day and 18% above its 50 day average. It is 28% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 66), near overbought. The nearest support is the Pivot S1 at $12.64, and the nearest resistance the swing high (Aug 11) at $13.25.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 6.1%/day
Key levels
$13.8552 week high+5.8%
$13.55Pivot R1+3.5%
$13.25Swing high (Aug 11)+1.2%
$13.09Pivot+0.0%
$13.09Last close
$12.64Pivot S1−3.4%
$11.2220 day average−14.3%
$10.94100 day average−16.4%
$10.88Swing low (Aug 24)−16.9%
$10.7950 day average−17.6%
$9.49200 day average−27.5%
$5.6552 week low−56.8%
Indicators
RSI (14)
65.99
Strong, overbought above 70
Neutral
MACD
0.70
Above its signal line
Bullish
Stochastic
88.0
Near the top of its range
Overbought
ADX (14)
26.4
Trending up
Williams %R
-16.3
Oversold below −80, overbought above −20
Overbought
CCI (20)
125.0
Oversold below −100, overbought above 100
Overbought
Rate of change
+33.4%
Change over 10 sessions
Bullish
ATR (14)
$0.80
Typical daily range, 6.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, nearing overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 10.5%/day
Key levels
$13.8552 week high+5.8%
$13.55Pivot R1+3.5%
$13.25Swing high (Aug 11)+1.2%
$13.09Pivot+0.0%
$13.09Last close
$12.64Pivot S1−3.4%
$11.2220 day average−14.3%
$10.94100 day average−16.4%
$10.88Swing low (Aug 24)−16.9%
$10.7950 day average−17.6%
$9.49200 day average−27.5%
$5.6552 week low−56.8%
Indicators
RSI (14)
65.88
Strong, overbought above 70
Neutral
MACD
0.55
Above its signal line
Bullish
Stochastic
52.8
Middle of its range
Neutral
ADX (14)
25.1
Trending up
Williams %R
-16.3
Oversold below −80, overbought above −20
Overbought
CCI (20)
195.2
Oversold below −100, overbought above 100
Overbought
Rate of change
+19.4%
Change over 10 sessions
Bullish
ATR (14)
$1.37
Typical daily range, 10.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for FENC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how FENC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow FENC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for FENCHow many large options trades hit FENC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in FENC in the last 90 days.
From SEC Form 4 filings by FENC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FENC is in one of them and how their past FENC trades turned out.
Fennec Pharmaceuticals is a pharmaceutical company based in Research Triangle Park, North Carolina. Its main product is PEDMARK, a sodium thiosulfate injection that the company develops and commercializes. The company relies on patents and licensed intellectual property to protect PEDMARK from competing generic versions. It works with licensors and collaborators on its technologies and product.